Literature DB >> 2201571

Comparison of inhibitor binding in HIV-1 protease and in non-viral aspartic proteases: the role of the flap.

A Gustchina1, I T Weber.   

Abstract

The crystal structure of HIV-1 protease with an inhibitor has been compared with the structures of non-viral aspartic proteases complexed with inhibitors. In the dimeric HIV-1 protease, two 4-stranded beta-sheets are formed by half of the inhibitor, residues 27-29, and the flap from each monomer. In the monomeric non-viral enzyme the single flap does not form a beta-sheet with an inhibitor. The HIV-1 protease shows more interactions with a longer peptide inhibitor than are observed in non-viral aspartic protease-inhibitor complexes. This, and the large movement of the flaps, restricts the conformation of the protease cleavage sites in the retroviral polyprotein precursor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2201571     DOI: 10.1016/0014-5793(90)81171-j

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  A comparative study of HIV-1 and HTLV-I protease structure and dynamics reveals a conserved residue interaction network.

Authors:  Pia Rücker; Anselm H C Horn; Heike Meiselbach; Heinrich Sticht
Journal:  J Mol Model       Date:  2011-01-29       Impact factor: 1.810

2.  Molecular dynamics simulations of 14 HIV protease mutants in complexes with indinavir.

Authors:  Xianfeng Chen; Irene T Weber; Robert W Harrison
Journal:  J Mol Model       Date:  2004-09-28       Impact factor: 1.810

3.  Effect of flap mutations on structure of HIV-1 protease and inhibition by saquinavir and darunavir.

Authors:  Fengling Liu; Andrey Y Kovalevsky; Yunfeng Tie; Arun K Ghosh; Robert W Harrison; Irene T Weber
Journal:  J Mol Biol       Date:  2008-07-01       Impact factor: 5.469

Review 4.  Conformational selection in protein binding and function.

Authors:  Thomas R Weikl; Fabian Paul
Journal:  Protein Sci       Date:  2014-09-06       Impact factor: 6.725

5.  Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling.

Authors:  N Thanki; J K Rao; S I Foundling; W J Howe; J B Moon; J O Hui; A G Tomasselli; R L Heinrikson; S Thaisrivongs; A Wlodawer
Journal:  Protein Sci       Date:  1992-08       Impact factor: 6.725

6.  A look inside HIV resistance through retroviral protease interaction maps.

Authors:  Aleksejs Kontijevskis; Peteris Prusis; Ramona Petrovska; Sviatlana Yahorava; Felikss Mutulis; Ilze Mutule; Jan Komorowski; Jarl E S Wikberg
Journal:  PLoS Comput Biol       Date:  2007-01-24       Impact factor: 4.475

7.  Kinetic and thermodynamic characterisation of HIV-protease inhibitors against E35D↑G↑S mutant in the South African HIV-1 subtype C protease.

Authors:  Sibusiso Maseko; Eden Padayachee; Siyabonga Maphumulo; Thavendran Govender; Yasien Sayed; Glenn Maguire; Johnson Lin; Tricia Naicker; Sooraj Baijnath; Kruger Hendrik Gerhardus
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

Review 8.  Enhancing protein backbone binding--a fruitful concept for combating drug-resistant HIV.

Authors:  Arun K Ghosh; David D Anderson; Irene T Weber; Hiroaki Mitsuya
Journal:  Angew Chem Int Ed Engl       Date:  2012-01-31       Impact factor: 15.336

9.  Elasticity-Associated Functionality and Inhibition of the HIV Protease.

Authors:  Dean Sherry; Roland Worth; Yasien Sayed
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 10.  HIV Protease: Historical Perspective and Current Research.

Authors:  Irene T Weber; Yuan-Fang Wang; Robert W Harrison
Journal:  Viruses       Date:  2021-05-06       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.